{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:30:28Z","timestamp":1794573028350,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To understand perspectives on and preferences for preexposure prophylaxis (PrEP) for pregnant individuals who are at risk for human immunodeficiency virus (HIV) infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this qualitative study, we purposively sampled and conducted in-depth interviews with pregnant participants at risk of HIV infection (indicated by a recent sexually transmitted infection [STI]) from a U.S. urban obstetrics clinic. Interview questions focused on perceived HIV risk, knowledge and perceptions of PrEP, and preferences for different PrEP formulations. We coded data using deductive and inductive codes, created matrices to explore patterns in findings, and wrote memos to interpret emergent themes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Twenty patients were enrolled. Median age of the participants was 24 years (interquartile range 19\u201326 years), 95.0% were African American, 65.0% were high school graduates, and 70.0% had unplanned pregnancies. Participants had low knowledge of PrEP and most saw themselves at low to no risk of HIV acquisition, despite their recent STI. Further, participants' low HIV risk perception and medication safety concerns reduced PrEP acceptability. Moreover, very few had discussed PrEP with their obstetrician\u2013gynecologists (ob-gyns) during antenatal care, which further affected perceived acceptability. However, participants who did discuss PrEP with their ob-gyns had favorable perceptions of it. These participants indicated that they would choose a formulation based on individual preferences, which were largely shaped by perceived ease of use, acceptability, and prior experience with other medication regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Obstetrician\u2013gynecologists may play an important role in increasing pregnant individuals\u2019 knowledge of and access to PrEP during pregnancy among those who are at risk of HIV acquisition. To maximize uptake and adherence during this time, PrEP formulations should be tailored to individual preferences. Prevention of HIV during this critical life transition is important not only for the long-term health and well-being of pregnant individuals and their infants, but to the plan to end the HIV epidemic in the United States by 2030.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004709","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:09:12Z","timestamp":1646932152000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Preexposure Prophylaxis Acceptability Among Pregnant Individuals and Implications for Human Immunodeficiency Virus Prevention"],"prefix":"10.1097","volume":"139","author":[{"given":"Allison K.","family":"Groves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Vadaketh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie T.","family":"Raziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hervette","family":"Nkwihoreze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Momplaisir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study","volume":"366","author":"Gray","year":"2005","journal-title":"Lancet"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajog.2018.10.014","article-title":"Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention","volume":"220","author":"Bayigga","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/QAI.0000000000001225","article-title":"Sexual behavior and vaginal practices during pregnancy and postpartum: implications for HIV prevention strategies","volume":"74","author":"Kinuthia","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiy113","article-title":"Increased risk of female HIV-1 acquisition throughout pregnancy and postpartum: a prospective per-coital act analysis among women with HIV-1 infected partners","volume":"218","author":"Thomson","year":"2018","journal-title":"J Infect Dis"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0000000000001160","article-title":"Brief report: preventing HIV-1 infection in women using oral preexposure prophylaxis: a meta-analysis of current evidence","volume":"73","author":"Hanscom","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAD.0000000000001313","article-title":"Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding","volume":"31","author":"Mofenson","year":"2017","journal-title":"AIDS"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"e25463","DOI":"10.1002\/jia2.25463","article-title":"The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study","volume":"23","author":"Velloza","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","article-title":"PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: results from HPTN 082, a randomized controlled trial","volume":"18","author":"Celum","year":"2021","journal-title":"PLOS Med"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/apc.2018.0242","article-title":"Perceptions of HIV preexposure prophylaxis among young pregnant women from rural KwaZulu-Natal, South Africa","volume":"33","author":"Vazquez","year":"2019","journal-title":"AIDS Patient Care STDs"},{"key":"R14-20260916","article-title":"Those tablets, they are finding an empty stomach\u201d: a qualitative investigation of HIV risk among sexual and gender minority migrants in Cape Town, South Africa","author":"Alessi","year":"2020","journal-title":"Ethn Health"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2352-3018(21)00029-1","article-title":"Highlights of HIVR4P\/\/virtual","volume":"8","author":"Harris","year":"2021","journal-title":"Lancet HIV"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1089\/jwh.2018.7353","article-title":"Factors affecting pre-exposure prophylaxis implementation for women in the United States: a systematic review","volume":"28","author":"Bradley","year":"2019","journal-title":"J Womens Health"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10461-020-03023-9","article-title":"Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the women's interagency HIV study (WIHS): a qualitative study across six cities in the United States","volume":"25","author":"Philbin","year":"2021","journal-title":"AIDS Behav"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ev.1427","article-title":"But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation","volume":"1986","author":"Lincoln","year":"1986","journal-title":"New Dir Program Eval"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.AOG.0000446855.78026.21","article-title":"Preexposure prophylaxis for the prevention of human immunodeficiency virus","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R27-20260916","article-title":"Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women","author":"Scott","year":"2021","journal-title":"AIDS Care"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/S2352-3018(19)30335-2","article-title":"Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme","volume":"7","author":"Kinuthia","year":"2020","journal-title":"Lancet HIV"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0956462419863216","article-title":"Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa","volume":"30","author":"DiTullio","year":"2019","journal-title":"Int J STD AIDS"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/09540121.2018.1533234","article-title":"Perceived HIV risk as a predictor of sexual risk behaviors and discrimination among high-risk women","volume":"31","author":"Sewell","year":"2019","journal-title":"AIDS Care"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/09540121.2018.1447079","article-title":"HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system","volume":"30","author":"Rutledge","year":"2018","journal-title":"AIDS Care"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/apc.2014.0142","article-title":"Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV","volume":"29","author":"Auerbach","year":"2015","journal-title":"AIDS Patient Care STDs"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jana.2018.03.005","article-title":"PrEParing women to prevent HIV: an integrated theoretical framework to PrEP Black women in the United States","volume":"29","author":"Lambert","year":"2018","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAI.0000000000002377","article-title":"Black cisgender women's PrEP knowledge, attitudes, preferences, and experience in Chicago","volume":"84","author":"Hirschhorn","year":"2020","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jana.2017.11.002","article-title":"Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP","volume":"29","author":"Turner","year":"2018","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"2150132719878526","DOI":"10.1177\/2150132719878526","article-title":"Knowledge, attitudes, and PrEP prescribing practices of health care providers in Philadelphia, PA","volume":"10","author":"Carter","year":"2019","journal-title":"J Prim Care Community Health"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40615-017-0350-4","article-title":"The effects of race and racial concordance on patient-physician communication: a systematic review of the literature","volume":"5","author":"Shen","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/apc.2019.0242","article-title":"Contraception as a potential gateway to pre-exposure prophylaxis: US women's pre-exposure prophylaxis modality preferences align with their birth control practices","volume":"34","author":"Calabrese","year":"2020","journal-title":"AIDS Patient Care STDs"},{"key":"R39-20260916","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","article-title":"Young women's stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa","volume":"80","author":"Minnis","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-20260916","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.7448\/IAS.19.1.20875","article-title":"Stated product formulation preferences for HIV pre\u2010exposure prophylaxis among women in the VOICE\u2010D (MTN\u2010003D) study","volume":"19","author":"Luecke","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"R41-20260916","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/13557858.2018.1439896","article-title":"Gendered racism and the sexual and reproductive health of Black and Latina women","volume":"25","author":"Rosenthal","year":"2020","journal-title":"Ethn Health"},{"key":"R43-20260916","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JNC.0000000000000233","article-title":"Just4Us: development of a counselor-navigator and text message intervention to promote PrEP uptake among cisgender women at elevated risk for HIV","volume":"32","author":"Teitelman","year":"2021","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jwh.2019.8217","article-title":"The impact of HIV pre-exposure prophylaxis (PrEP) counseling on PrEP knowledge and attitudes among women seeking family planning care","volume":"30","author":"O\u2019Connell","year":"2021","journal-title":"J Womens Health"},{"key":"R45-20260916","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2147\/PPA.S315543","article-title":"Preference for and efficacy of a PrEP decision aid for women with substance use disorders","volume":"15","author":"Meyer","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"R46-20260916","doi-asserted-by":"crossref","first-page":"e0253280","DOI":"10.1371\/journal.pone.0253280","article-title":"Tonse Pamodzi: developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding","volume":"16","author":"Hill","year":"2021","journal-title":"PLoS One"},{"key":"R47-20260916","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/QAI.0000000000002814","article-title":"Improving quality of PrEP counseling for adolescent girls and young women in Kenya with standardized patient actors: a dose-response analysis","volume":"89","author":"Larsen","year":"2022","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:24Z","timestamp":1789556604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004709","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"2021-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}